BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15001125)

  • 1. Parenteral nutrition associated liver disease.
    Kaufman SS; Gondolesi GE; Fishbein TM
    Semin Neonatol; 2003 Oct; 8(5):375-81. PubMed ID: 15001125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing parenteral nutrition liver disease.
    Kelly DA
    Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis.
    Willis TC; Carter BA; Rogers SP; Hawthorne KM; Hicks PD; Abrams SA
    JPEN J Parenter Enteral Nutr; 2010; 34(1):32-7. PubMed ID: 19587385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease in infants receiving total parenteral nutrition.
    Postuma R; Trevenen CL
    Pediatrics; 1979 Jan; 63(1):110-5. PubMed ID: 108658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing liver dysfunction in parenteral nutrition.
    Lloyd DA; Gabe SM
    Proc Nutr Soc; 2007 Nov; 66(4):530-8. PubMed ID: 17961274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver complications associated with short-term parenteral nutrition in children].
    Moreno Villares JM; Gomis Muñoz P; Galiano Segovia MJ; Valero Zanuy MA; Serrano Garrote O; León Sanz M
    An Esp Pediatr; 1999 Jul; 51(1):22-6. PubMed ID: 10452141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT; Nespor C; Kerner J
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum B12 concentration is elevated in patients receiving chronic parenteral nutrition, but is not a marker of intestinal failure-associated liver disease.
    Elkhatib I; Cao W; Rao S; Fryer J; Buchman AL
    J Clin Gastroenterol; 2010 Sep; 44(8):571-4. PubMed ID: 20421811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?
    Nasr A; Diamond IR; de Silva NT; Wales PW
    J Pediatr Surg; 2010 May; 45(5):980-6. PubMed ID: 20438939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics.
    Chungfat N; Dixler I; Cohran V; Buchman A; Abecassis M; Fryer J
    J Am Coll Surg; 2007 Dec; 205(6):755-61. PubMed ID: 18035258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
    Nehra D; Fallon EM; Puder M
    Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective intestinal decontamination and parenteral nutrition related liver disease. Experimental study].
    García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
    Cir Pediatr; 2006 Jul; 19(3):147-50. PubMed ID: 17240945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 lipids for intestinal failure associated liver disease.
    Diamond IR; Pencharz PB; Wales PW
    Semin Pediatr Surg; 2009 Nov; 18(4):239-45. PubMed ID: 19782305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease due to parenteral and enteral nutrition.
    Kwan V; George J
    Clin Liver Dis; 2004 Nov; 8(4):893-913, ix-x. PubMed ID: 15464661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of parenteral nutrition-associated liver disease in infants with necrotizing enterocolitis before and after the implementation of feeding guidelines.
    Tillman EM; Norman JL; Huang EY; Lazar LF; Crill CM
    Nutr Clin Pract; 2014 Apr; 29(2):234-7. PubMed ID: 24569791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged parenteral nutrition after neonatal gastrointestinal surgery. A Danish experience.
    Christensen AE; Qvist N; Husby S
    Dan Med Bull; 2002 Aug; 49(3):244-7. PubMed ID: 12238285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.